Joy as first breast cancer drug approved for widespread use in ten years

… under the patient access scheme.
Breast Cancer Now welcomed the decision, saying … Delyth Morgan, chief executive at Breast Cancer Now, said: “This is immensely … life-extending alternative for patients whose breast cancer has become resistant to other …